KRYS
Price
$166.16
Change
+$0.47 (+0.28%)
Updated
May 2 closing price
Capitalization
4.8B
3 days until earnings call
VKTX
Price
$29.36
Change
+$0.75 (+2.62%)
Updated
May 2 closing price
Capitalization
3.3B
81 days until earnings call
Ad is loading...

KRYS vs VKTX

Header iconKRYS vs VKTX Comparison
Open Charts KRYS vs VKTXBanner chart's image
Krystal Biotech
Price$166.16
Change+$0.47 (+0.28%)
Volume$228.17K
Capitalization4.8B
Viking Therapeutics
Price$29.36
Change+$0.75 (+2.62%)
Volume$4.45M
Capitalization3.3B
KRYS vs VKTX Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. VKTX commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and VKTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (KRYS: $166.16 vs. VKTX: $29.36)
Brand notoriety: KRYS and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 78% vs. VKTX: 100%
Market capitalization -- KRYS: $4.8B vs. VKTX: $3.3B
KRYS [@Biotechnology] is valued at $4.8B. VKTX’s [@Biotechnology] market capitalization is $3.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 6 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • KRYS’s TA Score: 6 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than VKTX.

Price Growth

KRYS (@Biotechnology) experienced а -1.13% price change this week, while VKTX (@Biotechnology) price change was +17.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.8B) has a higher market cap than VKTX($3.3B). KRYS YTD gains are higher at: 6.064 vs. VKTX (-27.038). KRYS has higher annual earnings (EBITDA): 110M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. KRYS (598M). VKTX has less debt than KRYS: VKTX (1M) vs KRYS (7.26M). KRYS has higher revenues than VKTX: KRYS (291M) vs VKTX (0).
KRYSVKTXKRYS / VKTX
Capitalization4.8B3.3B146%
EBITDA110M-171.93M-64%
Gain YTD6.064-27.038-22%
P/E Ratio55.23N/A-
Revenue291M0-
Total Cash598M852M70%
Total Debt7.26M1M726%
FUNDAMENTALS RATINGS
KRYS vs VKTX: Fundamental Ratings
KRYS
VKTX
OUTLOOK RATING
1..100
824
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
2069
SMR RATING
1..100
6734
PRICE GROWTH RATING
1..100
5663
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (47) in the Biotechnology industry is in the same range as KRYS (79) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (69) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

VKTX's SMR Rating (34) in the Biotechnology industry is somewhat better than the same rating for KRYS (67) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew somewhat faster than KRYS’s over the last 12 months.

KRYS's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as VKTX (63) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

KRYS's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as VKTX (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AICFX57.151.11
+1.98%
American Funds Invmt Co of Amer F1
MDEFX21.60N/A
N/A
BlackRock International Select Eq Inv A
LVOFX17.76N/A
N/A
Lord Abbett Value Opportunities F
JDWAX111.26N/A
N/A
Janus Henderson Global Research A
ELCRX36.34N/A
N/A
Eaton Vance Growth R

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+0.28%
ACLX - KRYS
55%
Loosely correlated
+0.03%
IDYA - KRYS
51%
Loosely correlated
+2.25%
CRNX - KRYS
50%
Loosely correlated
+0.72%
CGON - KRYS
48%
Loosely correlated
+4.72%
ROIV - KRYS
48%
Loosely correlated
-0.86%
More